DIETARY STRATEGIES AND THERAPEUTIC AND PROPHYLACTIC APPROACHES TO THE RESTORATION OF REPRODUCTIVE FUNCTION DISORDERS IN OVERWEIGHT WOMEN
DOI:
https://doi.org/10.11603/24116-4944.2024.1.14736Keywords:
overweight, obesity, infertility, reproductive function, liraglutide, vitamin DAbstract
The aim of the study - to optimise dietary strategies and therapeutic and prophylactic approaches to the restoration of reproductive function disorders in overweight women.
Materials and Methods. The effectiveness of the treatment and prevention program was evaluated in two groups of patients with excess body weight and impaired reproductive function: a personalized complex of dietary strategies and medication, taking into account the comorbidity of clinical conditions and risk factors was offered to the main group (50 patients); and generally accepted approaches were offered to the patients of comparison group (50 women). A special questionnaire and anthropometric study of indicators (weight, height, waist and hip circumference with determination of their ratio, body mass index) were applied.
Results and Discussion. It should be noted the effectiveness of the proposed therapy, which was manifested in a decrease in the severity of abdominal obesity and a reduction of body weight by an average of 12.2±3.3 kg (14.6 %), statistically significant from the baseline. There was a significant improvement in lipid metabolism, a positive trend in the correction of hypertriglyceridemia and normalisation of liver transaminases. 70.0 % of the patients showed normalisation of the rhythm and nature of the menstrual cycle.
Conclusions. The combination of dietary strategies, dosed physical activity and medication complex, taking into account risk factors and comorbidity of somatic and gynecological pathology, made it possible to achieve a decrease in the severity of abdominal obesity, a reduction of body weight by 14.6 %, as well as a normalization of the rhythm and nature of the menstrual cycle after 6 months of therapy.
References
Borshuliak, A.A., Andriiets, O.A., & Bodnariuk O.I. (2021). Faktory ryzyku vynyknennia porushennia menstrualnoi funktsii na tli ozhyrinnia. [Risk Factors for Menstrual Dysfunction on the Background of Obesity]. Medytsyna siohodni i zavtra – Medicine Today and Tomorrow, 90, 40-47. [in Ukrainian]
Hlamazda, M. (2021). Osoblyvosti menstrualnoi funktsii u zhinok z morbidnym ozhyrinniam. [Features of Menstrual Function in Women with Morbid Obesity]. Reproduktyvne zdorovia zhinky – Women's Reproductive Health, 9-10, 100–104. DOI: 10.30841/2708-8731.9-10.2021.252602 [in Ukrainian]
Korytko, O.O., Pankiv, I.V. (2019). Viddaleni rezultaty korektsii metabolichnykh porushen pry syndromi polikistoznykh yaiechnykiv pislia likuvannia metforminom. [Long-Term Results of Correction of Metabolic Disorders in Polycystic Ovary Syndrome after Treatment with Metformin]. Mizhnarodnyi zhurnal endokrynolohii – International Journal of Endocrinology, 15(8), 628-632. DOI: 10.22141/2224-0721.15.8.2019.191686 [in Ukrainian]
Paienok, O.S. (2021). Vplyv nadmirnoi masy tila ta ozhyrinnia na rozvytok porushen reproduktyvnoi funktsii v zhinok. [The Impact of Overweight and Obesity on the Development of Reproductive Disorders in Women]. Mizhnarodnyi zhurnal endokrynolohii – International Journal of Endocrinology, 17(7), 575-580. DOI: 10.22141/2224-0721.17.7.2021.244974 [in Ukrainian]
Khyts, A. (2021). Ozhyrinnia ta reproduktyvni naslidky: rol zhyrovoi tkanyny yak endokrynnoho orhanu na stan zdorovia zhinky. [Obesity and Reproductive Outcomes: Role of Adipose Tissue as an Endocrine Organ in Women's Health]. Ukr. med. Chasopys – Ukr. Med. Journal, 25 travnia – Mai 25 [Elektronna publikatsiia – Electron Publication] Retrieved from https://www.umj.com.ua/ [in Ukrainian]
Chaikivska, E.F., Yarotska, N.V., & Silina N.K. (2020). Osoblyvosti statusu vitaminu D u divchatok pubertatnoho viku z nealkoholnoiu zhyrovoiu khvoroboiu pechinky ta metabolichno nezdorovym ozhyrinniam. [Features of Vitamin D Status in Pubertal Girls with Non-Alcoholic Fatty Liver Disease and Metabolically Unhealthy Obesity]. Reproduktyvna endokrynolohiia –Reproductive Endocrinology, 6, 57-61. [in Ukrainian]
Bulavenko, O.V., Tatarchuk, T.F., & Kon`kov, D.G. (2018). Suchasni stratehiyi klinichnoho menedzhmentu defitsytu vitaminu D u praktytsi akushera-hinekoloha [Modern strategies of clinical management of vitamin D deficiency in the practice of obstetrician-gynecologist]. Reproduktivna endokrinodohiya - Reproductive endocrinology, 39, 83-90. [In Ukrainian]
Коrytko, О. (2021). Vplyv nadmirnoyi vahy ta ozhyrinnya na reproduktyvne zdorov'ya ta vahitnistʹ [Influence of overweight and obesity on reproductive health and carrying of a pregnancy]. Mizhnarodnyy endokrynolohichnyy zhurnal - International Journal of Endokrinology (Ukraine), 7.79, 22–26. DOI: 10.22141/2224-0721.7.79.2016.86415 [In Ukrainian]
Kelly, A.S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P.M., Marcus, C., Arslanian, S. (2020). NN8022-4180 trial investigators. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med., 382(22), 2117-2128. DOI: 10.1056/NEJMoa1916038.
Lee, K.X., Quek, K.F., & Ramadas, A. (2023). Dietary and lifestyle risk factors of obesity among young adults: a scoping review of observational studies. Curr Nutr Rep., 12(4), 733-743. DOI: 10.1007/s13668-023-00513-9.
Lin, C.H., Shao, L., Zhang, Y.M., Tu, Y.J., Zhang, Y., Tomlinson, B., … Liu, Z. (2020). An evaluation of liraglutide including its efficacy and safety for the treatment of obesity. Expert Opin Pharmacother, 21(3), 275-285. DOI: 10.1080/14656566.2019.1695779.
Pailler, M., Thibault, H., & Lamireau, T. (2022). Dépister le risque de surpoids et d’obésité infantiles [Screening for the risk of childhood overweight and obesity]. Rev. Prat. 72(10), 1117-1121.
Saunders, K.H., Umashanker, D., & Igel, L.I. (2018). Obesity Pharmacotherapy. Med Clin North Am., 102(1), 135-148. DOI: 10.1016/j.mcna.2017.08.010.
Silina, N. K., Dyumina, A.A. (2018). Pravylo vitaminu D v zhinochomu zdorov'yi. Ohlyad mizhnarodnykh doslidzhenʹ [The role of vitamin D in women’s health. Review of international studies]. Slovo pro zdorov’ya - A word about health, 5(17), 26-29.
Song, J.E., Ko, H.J., & Kim, A.S. (2024). Comparison of the efficacy of anti-obesity medications in real-world practice. Drug Des Devel Ther., 18, 845-858. DOI: 10.2147/DDDT.S445415
Tak, Y.J., Lee, S.Y. (2021). Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep., 10(1), 14-30. DOI: 10.1007/s13679-020-00422-w.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Actual Problems of Pediatrics, Obstetrics and Gynecology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
